Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram Effects on Cerebral Blood Flow
NCT05957094Unknown
- Sponsor
- University of British Columbia
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of citalopram in major depressive disorder (MDD) (2 arms), sponsored by University of British Columbia. Primary endpoints: Cerebral Blood Flow, Exercise Performance and 1 more. Status: unknown.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05957094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05957094.